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We investigated the impact of temporal lobe epilepsy surgery on sex hormones and menstrual cycles. Sixteen female patients
with temporal lobe epilepsy were investigated prior to surgery and 3, 6, and 12 months after surgery. The patients received
carbamazepine (CBZ) as monotherapy (10 patients) or in combination with other antiepileptic drugs (six patients). Antiepilep-
tic drugs were maintained after surgery. During the 1-year follow-up after surgery eight patients (50%) remained completely
free of seizures. In another four patients (25%) only rare disabling seizures occurred. There were no significant differences be-
tween pre-surgical and post-surgical serum concentrations of testosterone, free testosterone, prolactin, dehydroepiandrosterone
sulfate, growth hormone, cortisol and sex hormone binding globulin. There was, however, a significant increase in serum an-
drostenedione concentration 6 months post-surgically (P < 0.02). Documentation of menstrual cycles in addition to laboratory
parameters revealed individual post-surgical changes of the menstrual cycle in eight patients. Four patients had a change in men-
strual periodicity: two patients with complete seizure control had regular cycles instead of oligomenorrhoea and two patients
with incomplete seizure control had oligomenorrhoea instead of regular cycles. These data indicate that at least in some patients
with temporal lobe epilepsy surgical treatment influences menstrual periodicity.
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INTRODUCTION
Epileptic discharges from the temporal lobe may
have an impact on the release of hormones from the
hypothalamic–pituitary axis1, 2. Not surprisingly, en-
docrine dysfunction is a common finding in female
patients with temporal lobe epilepsy (TLE)3. Anovu-
latory cycles are detected in about one fourth to one
third of women with TLE, whereas this is a less com-
mon finding in healthy controls (4–8%) and in patients
with idiopathic generalized epilepsy (0%)4–6.
Epilepsy surgery is a well established therapy of
chronic focal epilepsy. In successfully treated patients
total seizure control is achieved7. If epilepsy surgery
has an impact on the epileptic disorder even beyond
the manifestation of seizures one would expect that
an endocrine dysfunction caused by epileptic dis-
charges will normalize following successful surgical
treatment. In order to prove this hypothesis we investi-




All patients were women suffering from chronic fo-
cal epilepsy intractable to anticonvulsant drugs. Their
age varied between 21 and 42 years (mean 31.6 years).
They received carbamazepine (CBZ) as monotherapy
or in combination with other anticonvulsants (Table 1).
Anticonvulsant medication was maintained following
surgery. Seizure type, type of surgery and outcome are
listed in Table 1. Clinical as well as laboratory inves-
tigations and cranial magnetic resonance imaging ex-
cluded endocrine disorders in these patients. Informed
consent was obtained from all patients before investi-
gations were carried out.
Medical examination
All patients were medically examined prior to surgery
and 3, 6, and 12 months post-surgically.
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Table 1: Seizure type, antiepileptic drugs, type of surgery and outcome of patients.
Pat. No. Age (y) Seizure type AED Surgery Outcome
1 42 SPS CBZ Left temporo-lateral 1
2 24 SPS, CPS CBZ, VPA Left temporo-basal 1
3 31 SPS, CPS CBZ Right SAHE 1
4 34 CPS CBZ Right 2/3 TL-ectomy 3
5 28 CPS CBZ Left temporo-polar 4
6 32 SPS, CPS, TCS CBZ, LTG Left SAHE 2
7 34 CPS CBZ, TGB Left SAHE 2
8 38 CPS CBZ Left SAHE 4
9 28 CPS CBZ, PB Right 2/3 TL-ectomy 2
10 35 CPS, TCS CBZ Left SAHE 1
11 25 CPS CBZ Right SAHE 1
12 35 CPS CBZ Right SAHE 1
13 33 CPS CBZ Right SAHE 1
14 34 SPS, CPS CBZ, PB Left 2/3 TL-ectomy 3
15 33 SPS, CPS CBZ Left SAHE 2
16 21 CPS CBZ, PB Left fronto-lateral 1
SPS = simple partial seizures; CPS = complex partial seizures; TCS = tonic–clonic seizures; CBZ = carbamazepine; TGB = tiagabine; LTG
= lamotrigine; PB = phenobarbitone; VPA = valproate; SAHE = selective amygdalo-hippocampectomy; TL = temporal lobe.
Outcome of surgery was classified in accordance
to the proposal by Engel et al.8: class 1, free of
disabling seizures; class 2, rare disabling seizures;
class 3, worthwhile improvement; class 4, no worth-
while improvement.
Clinical endocrinological investigations were car-
ried out to exclude the possibility of additional dis-
eases that might affect the endocrine system. Cerebral
magnetic resonance imaging (MRI) performed on all
patients excluded morphological lesions in the pitui-
tary.
Laboratory investigations
For laboratory investigations (pre-surgical and 3, 6 and
12 months after surgery), venous blood samples were
withdrawn between 8 and 10 a.m. after an overnight
fast. A heparin-lock venous cannula was placed in
a forearm vein and, after a 30-minute rest, 20 ml
of blood was withdrawn through the cannula. Serum
samples were stored at −20 ◦C prior to the assays for
circulating hormones and sex hormone binding globu-
lin (SHBG). None of the patients had had a seizure
within 12 hours before blood sampling.
Hormone measurement included luteinizing hor-
mone (LH), follicle stimulating hormone (FSH), estra-
diol (E2), progesterone, testosterone (T), free testos-
terone (free T), androstenedione, prolactin (PRL),
dehydroepiandrosterone sulfate (DHEAS), cortisol,
human growth hormone (hGH), and sex hormone-
binding globulin (SHBG).
Analyses and assays
Hormones and SHBG were measured by commercial
enzyme immunoassays or radioimmunoassays. These
methods including sensitivity and quality control data
have been described in detail in a recent publication of
our group9.
Definition of the phases of the menstrual cycles
Follicular phase was defined as day 1–14 of the cycle
with progesterone concentrations below 2.5 ng ml−1.
Luteal phase was defined as day 15 + x of the cy-
cle with progesterone >2.5 ng ml−1. Anovulation was
defined as day 15 + x of the cycle and progesterone
<2.5 ng ml−1.
Definition of the length of the menstrual cycles: cy-
cle length 26–30 days (regular cycle); cycle length
>35 days (oligomenorrhoea).
Statistical methods
Data are expressed as mean ± standard of mean
(SEM). Statistical comparisons were carried out by us-
ing the Mann–Whitney U Test. A P value less than
0.05 was considered significant.
RESULTS
During the 1-year follow-up after surgery eight
patients (50%) remained completely free of seizures
(outcome class 1, Table 1). In another four patients
(25%) only rare disabling seizures occurred (outcome
class 2, Table 1). Antiepileptic drugs (AEDs) were
maintained following surgery. All patients received
carbamazepine (CBZ), 10 patients as monotherapy, six
patients in combination with other AEDs (Table 1).
Prior to surgery the daily dosage of CBZ was 1200–
2400 mg day−1 (mean 1623 mg day−1) with CBZ
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Table 2: Mean pre- and post-surgical serum concentrations (lower and upper range of 95% confidence intervals in brackets) of
hormones and binding globulin.
Testo. f. Testo. SHBG PRL DHEAS Androst.
[nmol l−1] [pg ml−1] [nmol l−1] [µg dl−1] [µg dl−1] [µg l−1]
Pre- 27.35 1.38 94.87 10.64 1065.4 1.64
surgical (14.8–39.9) (0.9–1.8) (77.2–112.5) (3.6–17.7) (609.5–1521.4) (1.2–2.1)
N = 16 N = 16 N = 16 N = 16 N = 14 N = 13
3 months 35.48 2.09 95 6.74 1063.5 1.90
(24.8–46.2) (0.6–3.5) (77.7–112.3) (0.1–13.4) (371.7–1755.3) (1.5–2.3)
N = 13 N = 13 N = 12 N = 13 N = 13 N = 12
Post- 6 months 41.05 1.44 99.5 3.25 984.6 2.63∗
surgical (31.5–50.6) (1.1–1.8) (76.6–122.4) (2.2–4.3) (479.6–1489.7) (2.0–3.3)
N = 12 N = 12 N = 12 N = 12 N = 11 N = 12
12 months 29.47 1.24 99.16 3.68 896.54 2.31
(17.0–42.0) (0.9–1.5) (77.0–121.4) (2.7–4.7) (276.0–1517.1) (1.8–2.8)
N = 11 N = 12 N = 12 N = 11 N = 11 N = 11
Testo. = testosterone; f. Testo. = free testosterone; SHBG = sexual hormone binding globulin; PRL = prolactin; DHEAS =
dehydroepiandrosterone sulfate; Androst. = androstenedione; ∗ = P < 0.02.
serum concentrations between 5.8–13.8 µg ml−1
(mean 9.4 µg ml−1). One year after surgery daily
CBZ dosage was between 800–2400 mg day−1 (mean
1656 mg day−1) with CBZ serum concentrations be-
tween 5.7–14.3 µg ml−1 (mean 10µg ml−1).
Post-surgical hormone serum concentrations of T,
free T, PRL, DHEAS, hGH, cortisol and SHBG did
not demonstrate significant differences to pre-surgical
concentrations (Table 2). However, androstenedione
demonstrated a significant increase 6 months after
surgery (P < 0.02) (Table 2).
A subanalysis of the above listed hormones and of
SHBG in only those eight patients who achieved total
seizure control (outcome class 1) also did not demon-
strate significant differences between post-surgical
and pre-surgical hormone concentrations.
Based on the measurement of serum levels of LH,
FSH, progesterone and E2 as well as the documen-
tation of cycle length menstrual periodicity was ana-
lysed. These data allowed the analysis of post-surgical
changes of the menstrual cycles in only eight patients
(Table 3). Four of these patients showed a change in
menstrual periodicity: in the two patients in whom
complete seizure control was achieved (patient num-
bers 3 and 10, Table 3), regular cycles occurred instead
of oligomenorrhoea. In another two patients (numbers
6 and 9, Table 3) where incomplete seizure control had
been achieved, oligomenorrhoea occurred instead of
regular cycles.
DISCUSSION
Epileptic discharges from the temporal lobes may con-
tribute to endocrine disturbances in female patients
with focal epilepsy3. An increased rate of anovulatory
cycles has been demonstrated in patients with TLE5, 6.
Furthermore, the fertility rate is known to be reduced
in women suffering from epilepsy when compared to
the general population10.
The analysis of serum concentrations of sex hor-
mones as well as SHBG prior to surgery and during
a 1-year follow-up did not show significant changes
in the 16 patients investigated. This finding was in-
dependent of the success of epilepsy surgery. There
was one exception: serum androstenedione concen-
trations were significantly increased 6 months after
surgery. This was a transient finding no longer existent
12 months after surgery. It is unlikely that the increase
of serum androstenedione (a precursor of testosterone)
was responsible for the alteration of menstrual cy-
cle regularity11. Only an increase of serum testos-
terone concentrations (which was not the case in our
study) might have influenced menstrual cycles12, 13.
An explanation for the increase of serum androstene-
dione can hardly be given. A stress-related increase
of serum androstenedione concentrations has been de-
scribed 2 hours following surgery14. However, this
finding is not comparable to an increase 6 months after
surgery.
Many changes in serum concentrations of sex hor-
mones and the binding globulin observed in patients
with epilepsy have to be attributed to the treatment
with enzyme-inducing AEDs. In a previous study9
on 22 female patients with chronically treated focal
epilepsy we studied the possible influence of AED
treatment: TSH, DHEAS, follicular LH and luteal
phase E2 were significantly lower and PRL and SHBG
were significantly higher than in healthy controls. We
found increased SHBG levels, decreased LH levels
during the follicular phase and decreased E2 levels
during the luteal phase9. Serum concentrations of T
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Table 3: Pre- and post-surgical length of the menstrual cycles and phase of the cycles at the time of investigation.
Pat Pre-surgical Post-surgical
No. 3 months 6 months 12 months
mc-phase mc-length mc-phase mc-length mc-phase mc-length mc-phase mc-length
1 FP RC OV – FP – FP –
2 LP RC FP – – – – –
3 Anov OLM FP OLM FP RC FP –
4 LP RC FP RC – – – –
5 Anov OLM Anov OLM Anov OLM FP OLM
6 LP RC Anov OLM Anov OLM Anov –
7 – – Anov OLM – – – –
8 FP RC FP RC FP RC FP RC
9 FP RC – – – – LP OLM
10 LP OLM FP OLM FP RC FP RC
11 FP RC – – FP – – –
12 LP – FP – – – – –
13 LP – LP – LP – LP –
14 FP RC LP RC FP RC LP RC
15 LP RC FP RC FP RC FP –
16 LP – LP – LP – LP –
Mc-length = length of menstrual cycle; mc-phase = phase of the menstrual cycle; FP = follicular phase; LP = luteal phase; Anov =
anovulation; RC = regular cycle; OLM = oligomenorrhoea.
and free T remained unchanged9. Most of these fin-
dings were related to AED treatment, especially the
decrease in DHEAS and the increase in SHBG, as
has also been reported by other investigators15–18.
Since AED treatment was maintained during the post-
surgical follow-up, it is not surprising that serum con-
centrations of sex hormones and SHBG did not show a
significant change during the 12-month follow-ups in
the patients reported here.
If epilepsy surgery influences endocrine go-
nadotrophic dysfunction in female patients, men-
strual disorders should normalize following successful
surgery. The possible impact of epileptic discharges
from the temporal lobes on these endocrine functions
has been demonstrated in various studies1, 6, 19, 20.
The impact of epilepsy which is reported in humans
is supplemented by findings in animal models of
epilepsy21, 22. In experiments on female rats, Edwards
et al.22 tested the hypothesis that limbic seizures di-
rectly contribute to reproductive dysfunction. Seizures
arrested ovarian cyclicity in all amygdala-kindled ani-
mals. In our study, documentation of menstrual cy-
cles in addition to hormone measurements allowed
the analysis of post-surgical changes of the menstrual
cycle in eight patients. Four patients had a change
in menstrual periodicity: two patients with complete
seizure control had regular cycles instead of oligomen-
orrhoea and two other patients with incomplete seizure
control had oligomenorrhoea instead of regular cy-
cles. One might hypothesize that following successful
surgery, interictal epileptic activity will no longer be
able to disturb the functioning of the hypothalamic–
pituitary axis23, 24. Consequently, regular cycles may
develop in patients with oligomenorrhoea prior to
surgery.
In a retrospective analysis of menstrual cycles in 10
patients with temporal lobe surgery by Sosa et al.25,
seven patients reported a change in menstrual cycles,
i.e. a decrease in duration of menses (one patient),
bleeding between periods (one patient) and irregular
periods (five patients). The follow-up of these com-
plaints was at least 5 months.
The results of our study in 16 patients indicate that
at least in some patients with temporal lobe epilepsy
surgical treatment influences menstrual periodicity.
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